Results 71 to 80 of about 157 (83)
Some of the next articles are maybe not open access.

Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI

Journal of Pharmacology and Experimental Therapeutics, 1999
LY315920 is a potent, selective inhibitor of recombinant human, group IIA, nonpancreatic secretory PLA2 (sPLA2). In a chromogenic isolated enzyme assay, LY315920 inhibited sPLA2 activity with an IC50 of 9 +/- 1 nM or 7.3 x 10(-6) mole fraction, which approached the stiochiometric limit of this assay.
Niles Fox   +2 more
exaly   +3 more sources

Varespladib (LY315920) effectively reverses experimental neuro-myotoxic effects in a pig model of lethal envenoming by Taipan (O. scutellatus) and Mojave rattlesnake (C. scutulatus)

Toxicon, 2020
L.L. Gilliam   +8 more
openaire   +1 more source

Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2

Toxicon, 2019
José Maria Gutierrez   +2 more
exaly  

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides

Journal of Medicinal Chemistry, 1996
David W Snyder, Noel D Jones, D W Snyder
exaly  

Highly Specific and Broadly Potent Inhibitors of Mammalian Secreted Phospholipases A2

Journal of Medicinal Chemistry, 2008
Michael Gelb   +2 more
exaly  

Home - About - Disclaimer - Privacy